The amount of annual maintenance fee payable under the agreement.

No definition available.

Name:	aytu_AnnualMaintenanceFeePayable
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.

+ References

No definition available.

+ Details

Name:	aytu_AssetAcquisitionConsiderationTransferred
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of consideration transferred for transaction cost incurred in asset acquisition.

+ References

No definition available.

+ Details

Name:	aytu_AssetAcquisitionConsiderationTransferredForTransactionCost
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	aytu_AssetAcquisitionLineItems
Namespace Prefix:	aytu_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the information pertaining to for contingent consideration arrangements recognized in connection with an asset purchase, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.

+ References

No definition available.

+ Details

Name:	aytu_AssetPurchaseContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The number of payments for contingent consideration under the business acquisition.

+ References

No definition available.

+ Details

Name:	aytu_BusinessAcquisitionContingentConsiderationNumberOfPayments
Namespace Prefix:	aytu_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

The amount of payment per each sales milestone of contingent consideration of the business acquisition.

+ References

No definition available.

+ Details

Name:	aytu_BusinessAcquisitionContingentConsiderationPaymentUponEachSalesMilestone
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The first revenue milestone for contingent value rights holders of the business acquisition.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationContingentValueRightsFirstRevenueMilestone
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Contingent value rights revenue milestone not met during the year.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationContingentValueRightsRevenueMilestoneNotMetDuringYear
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The minimum amount of annual royalties that must be generated for one product in the event that minimum sales volume is not generated.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMinimumAnnualRoyalties
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The percentage of net revenues generated for royalty payments, assumed as of the acquisition date.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesRoyaltyPaymentsPercentageOfRevenues
Namespace Prefix:	aytu_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of balloon payment under contractual obligation.

+ References

No definition available.

+ Details

Name:	aytu_ContractualObligationBalloonPayment
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of monthly payment under contractual obligation.

+ References

No definition available.

+ Details

Name:	aytu_ContractualObligationMonthlyPayment
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of gain (loss) from change in fair value of CVR.

+ References

No definition available.

+ Details

Name:	aytu_GainLossFromChangeInFairValueOfCVR
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of milestone payment payable under the license agreement

+ References

No definition available.

+ Details

Name:	aytu_LicenseAgreementMilestonePaymentPayable
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of license option fee payable under the agreement.

+ References

No definition available.

+ Details

Name:	aytu_LicenseOptionFeePayable
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of cash outflow for fixed obligation to investor.

+ References

No definition available.

+ Details

Name:	aytu_PaymentsForFixedObligationsToInvestor
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of cash outflow for fixed obligations during the period.

+ References

No definition available.

+ Details

Name:	aytu_RepaymentsOfFixedObligation
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The number of shares of stock issued during the period to the contingent value rights holders.

+ References

No definition available.

+ Details

Name:	aytu_StockIssuedDuringPeriodSharesContingentValueRights
Namespace Prefix:	aytu_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The value of stock issued during the period for contingent value rights.

+ References

No definition available.

+ Details

Name:	aytu_StockIssuedDuringPeriodValueContingentValueRights
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of net revenues to be reached to trigger the first milestone obligation of the supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionAgreementFirstMilestoneMinimumNetRevenues
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of make-whole payment per unit for sales under the minimum units for the supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionAgreementMakeWholePaymentPerUnitForSalesUnderMinimum
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The maximum amount of milestone obligations of the supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionAgreementMaximumMilestoneObligations
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The maximum amount of make-whole payment per year under supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionAgreementMaximumYearlyMakeWholePayment
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Th minimum amount of units to be sold per year under supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionAgreementMinimumSalesPerYear
Namespace Prefix:	aytu_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

Period covered by the supply and distribution commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionCommitmentPeriod
Namespace Prefix:	aytu_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The percentage of net sales that is to be paid in total for royalties under the supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionCommitmentTotalRoyaltyPercentageOfNetSales
Namespace Prefix:	aytu_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of liability recognized arising from contingent consideration in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 35
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.

+ References

No definition available.

+ Details

Name:	us-gaap_ContractualObligation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308

+ Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Term of the unrecognized unconditional purchase obligation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308

+ Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	aytu_AssetAcquisitionAxis=aytu_RumpusMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=aytu_KarbinalAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=aytu_TrisPharmaIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_InnovusPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=aytu_UniversityOfIowaResearchFoundationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_NovalereMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=aytu_InnovusPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_PrescriptionDatabaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_ThePediatricPortfolioMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_FirstPediatricPortfolioFixedObligationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_SecondPediatricPortfolioFixedObligationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=us-gaap_InventoriesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=aytu_HikmaPharmaceuticalsUsaIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_ProductMilestonePaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_RumpusEarnOutPaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=aytu_OverNextSixQuartersCommencingSeptember302021Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=aytu_DenovoBiopharmaLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=aytu_JohnsHopkinsUniversityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=aytu_Beginning2022Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies - Narrative (Details)						1 Months Ended			3 Months Ended
Commitments and Contingencies - Narrative (Details)	Jun. 21, 2021 USD ($)	Apr. 12, 2021 USD ($)	Mar. 20, 2021 USD ($) shares	May 29, 2020 USD ($)	Mar. 31, 2020 USD ($) shares	Aug. 31, 2021 USD ($)	Jan. 31, 2020 USD ($)	May 31, 2016 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Dec. 31, 2021 USD ($)	Jul. 31, 2021 USD ($)	Jul. 01, 2021 USD ($)	Jun. 30, 2021 USD ($)	Jan. 31, 2021 USD ($)	Feb. 14, 2020 USD ($)	Nov. 01, 2019 USD ($)	Feb. 28, 2015 USD ($)
Commitments and Contingencies
Contractual obligation									$ 30,533,000
Rumpus
Commitments and Contingencies
Up-front fee		$ 1,500,000
Payment of aggregated fees		600,000
Contingent consideration		67,500,000
Karbinal Agreement
Commitments and Contingencies
Supply and distribution commitment, period (in Years)									20 years
Percentage of net sales on royalty									23.50%
Maximum yearly make-whole payment									$ 2,100,000
Tris Pharma, Inc.
Commitments and Contingencies
Minimum sales per year												70,000
Tris Pharma, Inc. \| Karbinal Agreement
Commitments and Contingencies
Minimum sales per year												70,000
Make-whole payment per unit for sales under minimum												$ 30
Maximum milestone obligations						$ 3,000,000.0
First milestone, minimum net revenues						$ 40,000,000.0
Innovus
Commitments and Contingencies
Number of shares issued to contingent value rights share holders \| shares			103,190		123,820
Contingent value rights amount			$ 1,000,000.0		$ 2,000,000.0
First milestone			$ 30,000,000.0						24,000,000.0
Milestone not met during the year									1,000,000.0
Gain (loss) from change in fair value of CVR									47,000	$ (100,000)
Contingent consideration									300,000					$ 300,000		$ 200,000
Innovus \| University of Iowa Research Foundation
Commitments and Contingencies
Total milestone payments									200,000
Contingent consideration									45,000				$ 50,000	$ 100,000
Milestone payment payable									50,000
Novalere \| Innovus
Commitments and Contingencies
Number of Payments																		5
Total milestone payments																		$ 500,000
Contingent consideration									300,000
Prescription Database
Commitments and Contingencies
Payment								$ 1,600,000
Term of payment								3 years
Contractual obligation									679,000
Prescription Database \| The Pediatric Portfolio
Commitments and Contingencies
Payment							$ 600,000
First Pediatric Portfolio Fixed Obligation
Commitments and Contingencies
Monthly payment															$ 86,400
Balloon payment															$ 15,000,000.0
Repayments of fixed obligation				$ 15,000,000.0
Second Pediatric Portfolio Fixed Obligation
Commitments and Contingencies
Monthly payment																	$ 100,000
Payments for fixed obligations to investor	$ 2,800,000						$ 210,767
Repayments of fixed obligation	3,000,000.0
Inventories. \| Hikma Pharmaceuticals USA, Inc.
Commitments and Contingencies
Payment											$ 700,000
Product Milestone Payments
Commitments and Contingencies
Contractual obligation									3,000,000
Rumpus Earn Out Payments
Commitments and Contingencies
Contractual obligation									$ 846,000
Over Next Six Quarters Commencing September 30, 2021 \| Second Pediatric Portfolio Fixed Obligation
Commitments and Contingencies
Repayments of fixed obligation	$ 500,000
In-process R&D \| Rumpus
Commitments and Contingencies
Up-front fee		1,500,000
Payment of aggregated fees		600,000
Contingent consideration		67,500,000
In-process R&D \| Maximum \| Rumpus
Commitments and Contingencies
Contingent consideration		67,500,000
In-process R&D \| Denovo Biopharma L L C \| Rumpus
Commitments and Contingencies
Contingent consideration		101,700,000
Annual maintenance fee payable		25,000
License option fee payable		600,000
In-process R&D \| Johns Hopkins University \| Rumpus
Commitments and Contingencies
Contingent consideration		1,600,000
Minimum annual royalties		$ 5,000
Percentage of revenues on royalty payments		3.00%
In-process R&D \| Beginning 2022 \| Johns Hopkins University \| Rumpus
Commitments and Contingencies
Minimum annual royalties		$ 20,000